There is a common list of reimbursable medicines for the General Medical Services and Drug Payment schemes. This list is reviewed and amended monthly, as new products become available and deletions are notified. For an item to be reimbursed, it must comply with published criteria, including authorisation status as appropriate, price and, in certain cases, the intended use of the product. In addition, the product should ordinarily be supplied to the public only by medical prescription and should not be advertised or promoted to the public. Products are considered for reimbursement on application by a supplier.
Trasylol is not currently reimbursable through the state schemes. Any application by a supplier to have Trasylol included on the common list will be considered in the usual way. People who experience undue financial hardship in obtaining any particular product should contact the local area office of the Health Service Executive.